Generics
First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspected Opioid Overdose
10 June 2019 - - The first patient has been dosed in a Phase 1 clinical study that will examine pharmacokinetic properties of nalmefene hydrochloride, US-based Purdue Pharma L.P.'s said.
Th...
Dr. Reddy's Laboratories unveils Zenatane (Isotretinoin Capsules, USP) in 10 mg, 20 mg, 30 mg and 40 mg in the US
4 June 2019 - Pharmaceutical company Dr. Reddy's Laboratories Ltd (BSE:500124) (NSE:DRREDDY) (NYSE:RDY) on Monday announced the the re availability of Zenatane (Isotretinoin Capsules, USP) in 10 ...
Teva Launches Generic Version of Ranexa Extended-Release Tablets in the United States
30 May 2019 - - Israeli generic drug specialist Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) (TASE: TEVA) has launched a generic version of Ranexa1 (ranolazine) Extended-Release Tablets, 500...
MSN Labs/Novadoz Pharmaceuticals wins US FDA approvals for both generic Solifenacin and Trientine tablets
29 May 2019 - Novadoz Pharmaceuticals reported on Tuesday the receipt of US FDA approval to market the generic Solifenacin Succinate tablets in 5mg and 10mg tablets in 30 and 90 count bottles for trea...
Perrigo wins US FDA final approval for AB rated generic Voltaren Gel 1%
22 May 2019 - Healthcare company Perrigo Company plc (NYSE:PRGO)(TASE:PRGO) reported on Tuesday the receipt of the final approval from the US Food and Drug Administration for its AB rated Abbreviated ...
Teva Launches of a Generic Version of Delzicol Delayed-Release Capsules in the United States
16 May 2019 - - Israeli generic drug specialist Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) TODAY announced the launch of a generic version of Delzicol (mesalamine) delayed-rele...